DavidYoonLeeMD

Radiation Oncology • Bloomington, IN

Physician

Join to view full profile

Are you Dr. Lee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
2620 W Cota Dr
Bloomington, IN 47403
Phone+1 812-353-2800

Fax+1 812-335-9569

Summary

Dr. David Lee, MD is a radiation oncologist in Bloomington, Indiana. He is currently licensed to practice medicine in Indiana and Pennsylvania. He is affiliated with Indiana University Health Bloomington Hospital and Indiana University Health Bedford Hospital.

Education & Training

University of RochesterResidency, Radiation Oncology, 1996 - 2000
Mercy Catholic Medical CenterInternship, Transitional Year, 1995 - 1996
Rutgers Robert Wood Johnson Medical SchoolClass of 1994

Certifications & Licensure

IN State Medical License 2000 - 2025
PA State Medical License 1995 - 1996
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Start of enrollment: 2011 Jan 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
The role of defects in the reaction of chlorine atoms with alkanethiol self-assembled monolayers
David Y. Lee, Matthew M. Jobbins, Ashley R. Gans, S. Alex Kandel
Physical Chemistry Chemical Physics. 2013-10-17
2 citations
Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second-line antiandrogen therapy era
Isaac E. Kim, Thomas L. Jang, Sinae Kim, David Y. Lee, Daniel D. Kim
Cancer Medicine. 2021-10-29